Similarly, lncRNA maternally expressed gene 3 (MEG3) showed decreased expression levels in RB tissues and cell lines, and this was negatively associated with metastatic disease development and the IIRC stage due to MEG3 regulation of the Wnt/β-catenin and p53 pathways. Here, MEG3 is linked to metastatic neoplasm.